Cargando…
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
Several lines of evidence suggest that components of the tumor microenvironment, specifically basement membrane and extracellular matrix proteins, influence drug sensitivities. We previously reported differential drug sensitivity of tumor cells localized adjacent to laminin-rich extracellular matrix...
Autores principales: | Zoeller, Jason J., Bronson, Roderick T., Selfors, Laura M., Mills, Gordon B., Brugge, Joan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460247/ https://www.ncbi.nlm.nih.gov/pubmed/28649658 http://dx.doi.org/10.1038/s41523-017-0020-z |
Ejemplares similares
-
Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
por: Zoeller, Jason J., et al.
Publicado: (2017) -
Clinical evaluation of BCL-2/X(L) levels pre- and post- HER2-targeted therapy
por: Zoeller, Jason J., et al.
Publicado: (2021) -
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
por: Zervantonakis, Ioannis K., et al.
Publicado: (2017) -
Fibroblast–tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways
por: Zervantonakis, Ioannis K., et al.
Publicado: (2020) -
Identification of cancer genes that are independent of dominant proliferation and lineage programs
por: Selfors, Laura M., et al.
Publicado: (2017)